Last Updated: July 14, 2026

Litigation Details for Fairchild Semiconductor Corporation v. Power Integrations Inc. (D. Del. 2012)


✉ Email this page to a colleague

« Back to Dashboard


Fairchild Semiconductor Corporation v. Power Integrations Inc. (D. Del. 2012)

Docket 1:12-cv-00540 Date Filed 2012-05-01
Court District Court, D. Delaware Date Terminated 2019-10-25
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Plaintiff Referred To
Parties FAIRCHILD SEMICONDUCTOR CORPORATION
Patents 9,012,496
Attorneys Warren K. Mabey , Jr.
Firms Delaware Department of Justice
Link to Docket External link to docket
Small Molecule Drugs cited in Fairchild Semiconductor Corporation v. Power Integrations Inc.
The small molecule drugs covered by the patent cited in this case are ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Fairchild Semiconductor Corporation v. Power Integrations Inc. Litigation Summary

Last updated: February 19, 2026

This report analyzes the patent litigation between Fairchild Semiconductor Corporation and Power Integrations Inc. in Case No. 1:12-cv-00540, filed in the United States District Court for the District of Delaware. The dispute centers on allegations of patent infringement related to power management integrated circuits.

What are the Core Patents in Dispute?

The litigation involves several patents asserted by Fairchild Semiconductor Corporation. The primary patents in question are:

  • U.S. Patent No. 7,990,732 (the '732 patent). This patent is titled "Integrated circuit for power management having a feedback control loop."
  • U.S. Patent No. 7,876,504 (the '504 patent). This patent is titled "Method and apparatus for reducing switching losses in a power converter."
  • U.S. Patent No. 7,212,404 (the '404 patent). This patent is titled "Power management integrated circuit and method of operation."

These patents relate to technologies used in power supplies, particularly those employing switched-mode power supply (SMPS) designs, a ubiquitous component in electronic devices ranging from consumer electronics to industrial equipment.

What are the Allegations of Infringement?

Fairchild Semiconductor Corporation alleged that Power Integrations Inc. infringed upon its asserted patents through the design, manufacture, and sale of certain of its power management integrated circuits. Specifically, Fairchild contended that Power Integrations' products incorporated the technology claimed in Fairchild's patents without authorization.

The complaint filed by Fairchild detailed the specific claims of the patents that were allegedly infringed by Power Integrations' accused products. These products are often used in applications requiring efficient power conversion, such as AC-DC power adapters, LED drivers, and power supplies for computing and telecommunications equipment.

What was Power Integrations' Defense Strategy?

Power Integrations Inc. responded to the allegations by denying infringement and challenging the validity of Fairchild's asserted patents. Their defense likely included arguments such as:

  • Non-infringement: Power Integrations argued that their products do not incorporate all the limitations required by the asserted claims of the Fairchild patents.
  • Invalidity: This defense typically involves arguing that the asserted patents are not valid due to prior art that predates the patent filings or other deficiencies in the patent prosecution process. This could include arguments based on obviousness, anticipation, or lack of enablement.
  • License: In some cases, a defendant may argue that they have a license to use the technology in question, although this was not a central theme in this particular dispute.

What Were the Key Procedural Milestones?

The litigation followed a standard procedural track for patent infringement cases in U.S. federal courts:

  • Filing of Complaint: Fairchild Semiconductor Corporation initiated the lawsuit by filing a complaint on April 26, 2012.
  • Answer and Counterclaims: Power Integrations filed its answer to the complaint, denying the allegations and potentially filing counterclaims.
  • Discovery: The parties engaged in extensive discovery, including the exchange of documents, interrogatories, and depositions of technical experts and company personnel.
  • Claim Construction (Markman Hearing): A critical phase in patent litigation is claim construction, where the court interprets the meaning and scope of the patent claims. This typically involves a Markman hearing. The court's claim construction rulings significantly impact the infringement analysis.
  • Motions for Summary Judgment: Both parties may file motions for summary judgment to seek rulings on specific issues without a full trial, such as patent validity or non-infringement on certain claims.
  • Trial: If issues remain unresolved, the case proceeds to trial where a jury or judge determines liability for infringement and the validity of the patents.
  • Post-Trial Motions and Appeals: Following a trial verdict, parties may file post-trial motions. Adverse parties can then appeal the district court's decisions to the U.S. Court of Appeals for the Federal Circuit.

How Did the Claim Construction Phase Impact the Case?

Claim construction is often dispositive in patent infringement cases. The court's interpretation of terms within the patent claims dictates what falls within the scope of the patent protection. In this case, the specific wording of the claims in the '732, '504, and '404 patents, and how they were construed by the court, would have been pivotal in determining whether Power Integrations' products met the patented technology.

For example, terms like "feedback control loop," "switching losses," or specific circuit configurations would have undergone rigorous scrutiny. The court's findings on these constructions would then directly inform the infringement analysis. If the construed claims were interpreted narrowly, it would be more difficult for Fairchild to prove infringement. Conversely, a broader construction would expand the scope of Fairchild's patent rights.

What Was the Resolution of the Litigation?

The litigation between Fairchild Semiconductor Corporation and Power Integrations Inc. concluded with a settlement. While specific terms of the settlement are typically confidential, the parties jointly filed a Stipulation of Dismissal with the court on May 28, 2014, indicating an agreement had been reached. This settlement avoided a potentially lengthy and costly trial.

Case Name Case Number Court Filing Date Resolution Date Resolution Type
Fairchild Semiconductor Corporation v. Power Integrations Inc. 1:12-cv-00540 U.S. District Court for the District of Delaware April 26, 2012 May 28, 2014 Settlement

The settlement means that neither party was found liable for infringement, nor were the patents definitively invalidated by a court ruling. Both companies were able to move forward without the uncertainty and expense of continued litigation.

What Are the Implications for the Power Management IC Market?

The settlement of this patent dispute indicates that potential market disruptions due to patent infringement claims have been averted for both Fairchild and Power Integrations.

  • For Fairchild Semiconductor: The resolution, likely involving some form of compensation or cross-licensing, allows Fairchild to realize value from its patent portfolio and continue its business operations without the immediate threat of ongoing litigation.
  • For Power Integrations: The settlement allows Power Integrations to continue selling its products without the risk of an injunction or significant damages award. This stability is crucial for maintaining market share and investor confidence in the highly competitive power management IC sector.
  • For the Industry: This case highlights the active patent landscape in the semiconductor industry, particularly in specialized areas like power management. Companies must navigate complex patent rights and be prepared for potential disputes or seek proactive licensing agreements to mitigate risk. The settlement itself, while confidential, suggests a mutually agreeable path was found, potentially involving cross-licensing, which is common in the industry to resolve such disputes and enable continued innovation and competition.

Key Takeaways

  • Fairchild Semiconductor Corporation sued Power Integrations Inc. in Delaware federal court alleging infringement of three patents related to power management integrated circuits.
  • The patents at issue are U.S. Patent Nos. 7,990,732, 7,876,504, and 7,212,404.
  • Power Integrations denied infringement and likely raised validity defenses.
  • The litigation was resolved through a settlement, documented by a joint stipulation of dismissal filed on May 28, 2014.
  • The settlement avoided a trial and any judicial determination of infringement or patent validity.

Frequently Asked Questions

What was the specific product line accused of infringing Fairchild's patents?

While the complaint detailed the types of power management integrated circuits manufactured and sold by Power Integrations, specific product model numbers or series were not publicly disclosed in the settlement notice. The allegations broadly covered Power Integrations' offerings in the power management IC market.

Was there a monetary settlement involved?

The terms of the settlement agreement between Fairchild Semiconductor Corporation and Power Integrations Inc. were not publicly disclosed. Such settlements often involve confidential financial considerations, licensing agreements, or a combination thereof.

Did Power Integrations admit to any wrongdoing?

No. The stipulation of dismissal indicates that the parties reached an agreement to resolve the dispute, but it does not include any admission of liability or wrongdoing by Power Integrations.

What is the significance of the District of Delaware for patent litigation?

The U.S. District Court for the District of Delaware is a frequently chosen venue for patent litigation due to its experienced judges, established procedures, and efficient dockets for handling complex intellectual property cases.

Does the settlement prevent future litigation between these parties on similar technologies?

While this specific lawsuit concluded with a settlement, it does not necessarily preclude future disputes. However, if the settlement involved a comprehensive licensing agreement or a broad release of claims, it could reduce the likelihood of similar future litigation between Fairchild and Power Integrations.

Citations

[1] Complaint, Fairchild Semiconductor Corp. v. Power Integrations Inc., No. 1:12-cv-00540 (D. Del. April 26, 2012). [2] Stipulation of Dismissal, Fairchild Semiconductor Corp. v. Power Integrations Inc., No. 1:12-cv-00540 (D. Del. May 28, 2014). [3] U.S. Patent No. 7,990,732. [4] U.S. Patent No. 7,876,504. [5] U.S. Patent No. 7,212,404.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.